fda compounding semaglutide news october 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 Drugmakers battle pharmacies over compounded

This can make it challenging for adolescents and adults with needle anxiety to start their GLP-1 weight loss journey

Programs that offer live coaches and require check-ins each week or even every other week have been shown to retain up to 70% of clients at 6 months versus less than 20% for programs that operate exclusively through an app, he said

Currently, there are five types of microneedles, and depending on their material and design, they can be categorized as solid, coated, hollow, dissolvable, and hydrogel (Figure 2B)

GLP-1 treatment for diabetes and obesity Semaglutide, a GLP-1 receptor agonist, is the active ingredient in Ozempic for diabetes and in Wegovy for obesity

Whether insurance covers semaglutide depends on why your doctor is prescribing it, as the coverage landscape differs significantly between diabetes and weight loss indications